These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9682928)

  • 21. [Drug therapy of patients with emotionally unstable personality].
    Nissen T
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Psychopharmacologic treatment of personality disorders].
    Quante A; Röpke S; Merkl A; Anghelescu I; Lammers CH
    Fortschr Neurol Psychiatr; 2008 Mar; 76(3):139-48. PubMed ID: 18240112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacotherapy in personality disorders].
    Wedekind D; Bandelow B; Rüther E
    Fortschr Neurol Psychiatr; 2005 May; 73(5):259-67. PubMed ID: 15880304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of borderline personality disorder to the affective disorders.
    Kroll J; Ogata S
    Psychiatr Dev; 1987; 5(2):105-28. PubMed ID: 2888107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacotherapy in personality disorders: methodological issues and results].
    Pelissolo A; Lepine JP
    Encephale; 1999; 25(5):496-507. PubMed ID: 10598315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
    Leitner P; Serfling R
    Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy of borderline states.
    Brinkley JR
    Psychiatr Clin North Am; 1993 Dec; 16(4):853-84. PubMed ID: 7906031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
    Parsons B; Quitkin FM; McGrath PJ; Stewart JW; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin JG; Wager SG; Nunes E
    Psychopharmacol Bull; 1989; 25(4):524-34. PubMed ID: 2698483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The psychopharmacologic treatment of personality disorders.
    Klar H; Siever LJ
    Psychiatr Clin North Am; 1984 Dec; 7(4):791-801. PubMed ID: 6151648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
    Campbell M; Cueva JE
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1262-72. PubMed ID: 7592263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Personality disorder].
    André C
    Rev Prat; 2008 Mar; 58(5):551-6; quiz 575. PubMed ID: 18524115
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Off-label use of atypical antipsychotics in personality disorders.
    Rosenbluth M; Sinyor M
    Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for post-traumatic stress disorder.
    Sutherland SM; Davidson JR
    Psychiatr Clin North Am; 1994 Jun; 17(2):409-23. PubMed ID: 7937367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the treatment of borderline personality disorder.
    Gagliardi JP; Krishnan RR
    Psychopharmacol Bull; 2003; 37(1):30-46. PubMed ID: 14561947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.